Jupiter Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Jupiter Asset Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-58,509	Closed	-$5.72M	–	258
2018 Q3	$5.72M	Buy	58,509 +17,617	+43%	+$1.91M	0.16%	157
2018 Q2	$4.71M	Hold	40,892	–	–	0.14%	170
2018 Q1	$4.04M	Buy	+40,892	New	+$4.14M	0.12%	172
2017 Q4	–	Sell	-40,673	Closed	-$4.58M	–	233
2017 Q3	$4.58M	Hold	40,673	–	–	0.16%	144
2017 Q2	$4.56M	Buy	40,673 +788	+2%	+$89K	0.16%	146
2017 Q1	$4.65M	Buy	39,885 +4,252	+12%	+$471K	0.17%	154
2016 Q4	$3.75M	Buy	35,633 +5,633	+19%	+$590K	0.14%	165
2016 Q3	$3.31M	Hold	30,000	–	–	0.13%	173
2016 Q2	$4.37M	Hold	30,000	–	–	0.17%	156
2016 Q1	$4.3M	Hold	30,000	–	–	0.16%	149
2015 Q4	$4.64M	Hold	30,000	–	–	0.17%	143
2015 Q3	$4.29M	Hold	30,000	–	–	0.17%	140
2015 Q2	$4.31M	Hold	30,000	–	–	0.15%	163
2015 Q1	$4.23M	Buy	+30,000	New	+$4.62M	0.15%	166

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

Jupiter Asset Management's TARO Position: Q4 2018 in Review

Jupiter Asset Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2018, closing a stake of 58,509 shares — an estimated $5.72M sold.

Jupiter Asset Management first reported a position in TARO in Q1 2015 and held it in 14 quarters. The position peaked at $5.72M in Q3 2018. 94 funds tracked by Wall St. Rank hold TARO as of Q4 2018.

Jupiter Asset Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2018 after selling out during the quarter.
Jupiter Asset Management sold 58,509 Taro Pharmaceutical Industries Ltd. shares in Q4 2018, an estimated $5.72M.
Jupiter Asset Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2015 and held it in 14 quarters.
Jupiter Asset Management's Taro Pharmaceutical Industries Ltd. position peaked at $5.72M in Q3 2018.
94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2018.

Based on Jupiter Asset Management's 13F filing for Q4 2018, filed 11 Feb 2019.